Press release
Cold Agglutinin Disease Treatment Market 2034: FDA Approvals, Clinical Trials, Drugs, Prevalence, Companies and Market Forecast by DelveInsight | Apellis Pharma, Novartis, Incyte crp., Sanofi, Alexion Pharma
Cold Agglutinin Disease Treatment Market
To Know in detail about the Cold Agglutinin Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cold Agglutinin Disease Market Forecast
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Cold Agglutinin Disease Market Report:
• The Cold Agglutinin Disease market size was valued ~USD 190 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In 2023, Germany held the largest share of the CAD market within the EU4 and the UK, totaling approximately USD 18 million.
• In January 2024, In a Phase 1 clinical trial, Annexon Biosciences' experimental oral therapy, ANX1502, designed for autoimmune conditions like cold agglutinin disease (CAD), achieved the targeted blood levels when administered twice daily to healthy volunteers. ANX1502, delivered as a liquid suspension, was well-received with no significant adverse effects reported. The pharmacokinetics of ANX1502, detailing its distribution, metabolism, and elimination from the body, also indicated the feasibility of implementing a twice-daily dosing regimen for future proof-of-concept studies.
• In November 2023, BioCryst revealed plans to create an innovative oral treatment targeting CAD, aiming to inhibit the immune complement cascade. They anticipate choosing a primary candidate by 2025.
• In 2023, there were approximately 5,500 prevalent cases of CAD in the United States.
• In 2023, about 90% of CAD cases in the US were identified as type-specific primary cases, with the remaining 10% classified as secondary CAD.
• Within the EU4 and the UK, Germany had the highest number of prevalent CAD cases.
• In 2023, there were around 1,800 cases of CAD in males and approximately 2,660 cases in females in the US.
• Key Cold Agglutinin Disease Companies: Apellis Pharmaceuticals, Novartis, Incyte corporation, Sanofi, Alexion Pharmaceuticals, Novartis, and others
• Key Cold Agglutinin Disease Therapies: Pegcetacoplan, Iptacopan, Parsaclisib, SAR445088, Eculizumab, sutimlimab (BIVV009, Iptacopan, and others
• The Cold Agglutinin Disease epidemiology based on gender analyzed that Cold Agglutinin Disease frequency is usually more in females than in males
• The Cold Agglutinin Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cold Agglutinin Disease pipeline products will significantly revolutionize the Cold Agglutinin Disease market dynamics.
Cold Agglutinin Disease Overview
Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia characterized by the presence of cold-reacting autoantibodies, known as cold agglutinins, in the blood. These autoantibodies target and bind to red blood cells at temperatures lower than normal body temperature, leading to their premature destruction (hemolysis) when exposed to cold environments, such as cold weather or refrigeration.
Get a Free sample for the Cold Agglutinin Disease Market Report:
https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cold Agglutinin Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cold Agglutinin Disease Epidemiology Segmentation:
The Cold Agglutinin Disease market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Cold Agglutinin Disease
• Prevalent Cases of Cold Agglutinin Disease by severity
• Gender-specific Prevalence of Cold Agglutinin Disease
• Diagnosed Cases of Episodic and Chronic Cold Agglutinin Disease
Download the report to understand which factors are driving Cold Agglutinin Disease epidemiology trends @ Cold Agglutinin Disease Epidemiology Forecast
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cold Agglutinin Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cold Agglutinin Disease market or expected to get launched during the study period. The analysis covers Cold Agglutinin Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cold Agglutinin Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Cold Agglutinin Disease Therapies and Key Companies
• Pegcetacoplan: Apellis Pharmaceuticals
• Iptacopan: Novartis
• Parsaclisib: Incyte corporation
• SAR445088: Sanofi
• Eculizumab: Alexion Pharmaceuticals
• sutimlimab (BIVV009): Sanofi
• Iptacopan: Novartis
Discover more about therapies set to grab major Cold Agglutinin Disease market share @ Cold Agglutinin Disease Treatment Market
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cold Agglutinin Disease Market Strengths
• Several organizations and companies like Cold agglutinin disease foundation and Sanofi Genzyme are raising awareness about the disease which can lead to increased patient pool.
Cold Agglutinin Disease Market Opportunities
• Mild anemic patients because of CAD don't have such a pharmaceutical treatment option, so there is an unsaid need for the drugs in mild anemic patients.
Scope of the Cold Agglutinin Disease Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Cold Agglutinin Disease Companies: Apellis Pharmaceuticals, Novartis, Incyte corporation, Sanofi, Alexion Pharmaceuticals, Novartis, and others
• Key Cold Agglutinin Disease Therapies: Pegcetacoplan, Iptacopan, Parsaclisib, SAR445088, Eculizumab, sutimlimab (BIVV009, Iptacopan, and others
• Cold Agglutinin Disease Therapeutic Assessment: Cold Agglutinin Disease current marketed and Cold Agglutinin Disease emerging therapies
• Cold Agglutinin Disease Market Dynamics: Cold Agglutinin Disease market drivers and Cold Agglutinin Disease market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Cold Agglutinin Disease Unmet Needs, KOL's views, Analyst's views, Cold Agglutinin Disease Market Access and Reimbursement
To know more about Cold Agglutinin Disease companies working in the treatment market, visit @ Cold Agglutinin Disease Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Cold Agglutinin Disease Market Report Introduction
2. Executive Summary for Cold Agglutinin Disease
3. SWOT analysis of Cold Agglutinin Disease
4. Cold Agglutinin Disease Patient Share (%) Overview at a Glance
5. Cold Agglutinin Disease Market Overview at a Glance
6. Cold Agglutinin Disease Disease Background and Overview
7. Cold Agglutinin Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Cold Agglutinin Disease
9. Cold Agglutinin Disease Current Treatment and Medical Practices
10. Cold Agglutinin Disease Unmet Needs
11. Cold Agglutinin Disease Emerging Therapies
12. Cold Agglutinin Disease Market Outlook
13. Country-Wise Cold Agglutinin Disease Market Analysis (2020-2034)
14. Cold Agglutinin Disease Market Access and Reimbursement of Therapies
15. Cold Agglutinin Disease Market Drivers
16. Cold Agglutinin Disease Market Barriers
17. Cold Agglutinin Disease Appendix
18. Cold Agglutinin Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Reports:
• Acute Heart Failure Ahf Market: https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
• Alstrom Syndrome Market: https://www.delveinsight.com/report-store/alstrom-syndrome-market
• Biliary Tract Carcinoma Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Plaque Psoriasis Market: https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
• Neurofibromatosis 2 Market: https://www.delveinsight.com/report-store/neurofibromatosis-2-market
• Penicillinbinding Proteins Market: https://www.delveinsight.com/report-store/penicillin-binding-proteins-market
• Acute On Chronic Liver Failure Aclf Market: https://www.delveinsight.com/infographics/acute-on-chronic-liver-failure-aclf-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
• Community-acquired Bacterial Pneumonia Market: https://www.delveinsight.com/report-store/community-acquired-bacterial-pneumonia-cabp-market
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-imn-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Clbp Market: https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market
• Corneal Endothelial Dystrophy Market: https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Refractory Angina Market: https://www.delveinsight.com/report-store/refractory-angina-market
• Stable Angina Market: https://www.delveinsight.com/report-store/angina-angina-pectoris-market
• Thrombocytopenia Market: https://www.delveinsight.com/report-store/thrombocytopenia-market
• Bacteremia Market: https://www.delveinsight.com/report-store/staphylococcus-aureus-bacteremia-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Beta Thalassemia Market: https://www.delveinsight.com/report-store/beta-thalassemia-market
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Chronic Hepatitis Delta Virus Market: https://www.delveinsight.com/infographics/hepatitis-d-market
• Heavy Metal Poisoning Market: https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
• Hepatorenal Syndrome Market: https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
• Hypoparathyroidism Market: https://www.delveinsight.com/report-store/hypoparathyroidism-market
• Ventricular Dysfunction Market: https://www.delveinsight.com/report-store/ventricular-dysfunction-market
• Chronic Obstructive Pulmonary Disease Copd Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Chronic Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Hereditary Spastic Paraplegias Market: https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
• Advanced Renal Cell Carcinoma Market: https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/sample-request/familial-primary-pulmonary-hypertension-market
• Healthcare Pipeline Analysis: https://www.delveinsight.com/consulting/pipeline-assessment-services
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Post Traumatic Stress Disorder Market: https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-market
• Spasticity Market: https://www.delveinsight.com/report-store/spasticity-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Becker Muscular Dystrophy Market: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
• Wegener S Granulomatosis/granulomatosis With Polyangiitis Market: https://www.delveinsight.com/report-store/wegeners-granulomatosis-market
• Artificial Lung Devices Market: https://www.delveinsight.com/report-store/artificial-lung-devices-pipeline-insight-and-competitive-landscape
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/infographics/diabetic-foot-ulcers-dfus-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cold Agglutinin Disease Treatment Market 2034: FDA Approvals, Clinical Trials, Drugs, Prevalence, Companies and Market Forecast by DelveInsight | Apellis Pharma, Novartis, Incyte crp., Sanofi, Alexion Pharma here
News-ID: 3627369 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
